Adult Stem Cells for Musculoskeletal Tissue Regeneration
AJAS · 2020 Biomedical and Health Sciences (inferred)
Overview
Adult mesenchymal stem cells (MSC) have been cited to have immunoregulatory effects in addition to their regenerative and multipotency capabilities, meaning they contribute to a regenerative environment that can help repair injuries in vivo and secrete bioactive macromolecules that regulate the immune response after injury. MSCs’ abilities include regulating inflammation, apoptosis, and angiogenesis by affecting immune cell lineages. A subset of MSCs of perivascular niche origin are characterized by the presence of the CD146 surface antigen. These CD146+ MSCs possess greater differential capabilities and immunoregulatory potential. This research compares the effectiveness of bone marrow (BM) MSCs and fat pad (FP) MSCs in responding to an inflammatory environment as well as pericytic MSCs compared to other MSCs. For each subset of stem cells tested, the inflammatory and growth factor profile was quantified in basal, non-inflammatory, conditions and after exposure to an inflammatory environment induced by human inflammatory cytokines TNFα and IFNγ. RT-PCR for the GAPDH, CD146, IL-6, IL-8, and IDO genes and ELISA human growth factor and inflammation antibody arrays were used to quantify changes in response to inflammation. Qualitative comparison of quantitative results suggests that CD146+ FP MSCs are the most effective subset of MSCs at responding to inflammation in vitro. As a result, CD146+ FP MSCs are the best stem cell subset to use for the millions of musculoskeletal injury treatments each year in order to regenerate injured tissue to shorten the healing process as well as prevent prolonged inflammation, scarring, and chronic tissue damage at injury sites.
Competition history
- AJAS 2020
Related projects
ISEF · 2022
Immunomodulatory Properties of Mesenchymal Stem Cells for Knee Osteoarthritis Prevention and Treatment
ISEF · 2026
TGF-ß3–Driven Reversal of Mesenchymal Stem Cell Senescence for Improved Regenerative Medicine Applications
ISEF · 2023
In Vitro Characterization of Umbilical Cord Mesenchymal Stem Cells (UC-MSCs) Supplemented With a Novel Xeno-Free, Human Blood-Derived Supplement
ISEF · 2016
Characterization of Mesenchymal Stem Cells Derived from Mouse Embryonic Stem Cells
AJAS · 2018
Investigation of the Therapeutic Potential of Umbilical Cord Tissue Derived Mesenchymal Stem Cells
ISEF · 2015
Mesenchymal Stem Cells: Innovations in Infection and Inflammation Therapy
ISEF · 2022
Pediatric BMSC Exosome Treatment Requires Interaction With Bone Tissue Defect Environment To Improve Bone Repair
ISEF · 2018
Evaluating the Potential of CD264 as an Effective Biomarker for Cellular Aging in Mesenchymal Stem Cells
Closest projects by meaning, across every fair and year in the corpus.
Browse more like this
Source: AAAS Annual Meeting (Confex) / American Junior Academy of Science